Back

Nationwide implementation of PCSK9--targeted therapies after myocardial infarction and ischemic stroke: structural barriers and disparities in a universal healthcare system

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Implementing novel lipid‑lowering therapies Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Petra Sedova

University Hospital Brno, Brno (Czechia)

4 More presentations in this session

Presentation thumbnail
The nocebo effect in statin therapy: clinical implications for adherence and cardiovascular outcomes
Doctor M. Sargsyan (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
Comparative effectiveness of lipid-lowering regimens for achieving ESC LDL-cholesterol targets in acute coronary syndrome: a real-world cohort analysis
Doctor A. Romiou (Marousi, GR)
Abstract Slides Video
Presentation thumbnail
Variability in lipoprotein(a) measurements in ODYSSEY OUTCOMES: is one-and-done testing sufficient?
Professor P. Steg (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Atorvastatin for prevention of chemotherapy-induced cardiotoxicity: a 5-year propensity-matched cohort study of 800 patients
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Implementing novel lipid‑lowering therapies

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Session
Changing face of lipid-lowering therapy
29 August 2025
thumbnail
Congress Presentation
Characteristics of patients initiating PCSK9i mAb following myocardial infarction and comparability of treatment groups in the Netherlands
28 August 2023
thumbnail
Congress Presentation
Comparing PCSK9 inhibitor prescription rates within high-risk populations: diabetes mellitus, multi-territory vascular disease, multivessel and recurrent coronary artery disease
30 August 2024
thumbnail
Congress Presentation
What about long-term prevention?
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources